Hi ,

After water, concrete is the most used material on Earth…but it has a terrible carbon footprint, read John Cumbers’ Forbes piece on Biomason founder Ginger Krieg Dosier, who is making sustainable concrete from microbes.

We hope you enjoy this week’s digest. If you know of colleagues who might enjoy it then they can sign up here.

It was so great to see everybody together at SynBioBeta last month! Here's a photo of Kristy Hawkins and Stephen Hubbard, founders of the Biotech Barbell Club:

In funding news, congratulations to Ingvar Helgason and the Vitrolabs team for raising $46 million to make cell-cultivated leather.

A huge congratulations to Jim Flatt and the team at Brightseed who recently raised a $68 million Series B. They are using artificial intelligence to find molecules in plants that could have the biggest health and nutrition benefits in humans.

In other news, Emerald Cloud Lab is doing some really interesting stuff with the Bioautomation Challenge. It's supported by Schmidt Futures.

Congratulations to Jason Kelly, Cofounder and CEO of Ginkgo Bioworks, for being ranked #5 in the Tech Power Players 50 list.

It was great to see so many old friends getting back together again last month (in the photo below, you can see Larry Stambaugh, Stephen Bates, and Mike Kamdar from Molecular Assemblies and Larry Upton of SynBioBeta). If you’re interested in long, pure synthetic DNA, sign up for Molecular Assemblies' Key Customer Program here.

Congrats to Derek Norman, Vice President of Venture Investments at Leaps by Bayer, for winning the Global Corporate Venturing 2022 Powerlist award. Derek has been a long-time attendee at SynBioBeta and it's an honor to see him recognized here.

Jasmina Aganovic, CEO of Arcaea, and Suveen Sahib, CEO of K18Hair, recently spoke at the WWD Beauty CEO Summit on the power of biotechnology and beauty.

Genoa Ventures, an early-stage venture fund started by Jenny Rooke, is welcoming a new partner, Vikram Chaudhery, and a VP of Finance, Amy Harris.

In this article, Reema AlYousef, Director of Community at Nucleate Dojo, reflects on Race Against the Clock (RATC) at the Built With Biology conference in Oakland, CA

MORE TO EXPLORE

• Record fertilizer prices drive investors, farmers to microbes: Companies such as Pivot Bio, Kula Bio and Anuvia are pushing development of farm fertilizers by harnessing microbes or plant-based products to deliver nutrients that corn and other crops need.
• Aldevron licenses the manufacturing of a TYPE-V CRISPR nuclease from Inscripta: A partnership between two CRISPR pioneers will provide the global scientific community with GMP MAD7™ nuclease.
• Scientists successfully grow plants in soil from the moon: The study is paramount to NASA's long-term goals in human space exploration. The research could also have implications for plants growing in harsh conditions on Earth.
• LanzaTech appoints Dr. Steven F. Stanley, as Chief Commercial Officer Stanley to lead the transformation of licensing division and build out multiple commercialization teams as LanzaTech prepares expansion into new markets.
• DNA Script appoints Chris Barbazette as Chief Commercial Officer. Industry veteran brings decades of experience building and scaling successful commercial strategies for leading life science and diagnostic companies
• CNN's 'Mission: Ahead' featuring Nanome. As more bacteria become resistant to existing antibiotics, scientists are turning to virtual reality to help design new medicines. Crane meets Steve McCloskey, co-founder and CEO of Nanome, a start-up which uses virtual reality to put researchers inside the molecules they study.
• Ziopharm vows to wow cancer field with synthetic biology drugs. Ziopharm CEO Jonathon Lewis believes he has the kind of game-changing technology that can revolutionize cancer therapy and radically drive down costs.
• Aquaculture experts to discuss role of synthetic biology in aquafeed. F3 will host an expert panel at its upcoming webinar, Synthetic biology: customizing nutrients for aquafeeds on 19 May.
• BigHat Biosciences appoints Rob Chess to its board of directors. BigHat Biosciences is designing safer, more effective next-generation antibody therapies for patients using machine learning and synthetic biology
• GenScript launches GMP single-strand and double-strand DNA service for supporting gene and cell therapy development: These services will enable next-generation gene and cell therapy R&D programs to advance to IND filing and clinical trials faster and more efficiently.
• Surface Active Foam Fractionation® technology now capable of removing short chain PFAS: Allonnia announced that EPOC Enviro’s SAFF PFAS remediation technology can remove almost all short chain PFAS compounds from many contaminated water types, as well as long chain PFAS compounds.

WHO'S HIRING?

• Engineering Technician, Inscripta, Pleasanton, CA
• Field Applications Scientist, North America - East, Inscripta, East Coast
• Senior Scientist, Inscripta, Pleasanton, CA
• Account Executive - Europe with focus on UK/BNL, Inscripta, United Kingdom or Denmark

Like our Digest? Please feel free to share with friends, family, and co-workers!

Built With Biology, LLC
3559 Mount Diablo Boulevard #2, Lafayette, CA 94549

info@builtwithbiology.com

If you no longer wish to receive our emails, you can unsubscribe here.
Modify Your Email Preferences